Cargando…

Overall Survival in Heart Disease–Related Death in Non-Small Cell Lung Cancer Patients: Nonimmunotherapy Versus Immunotherapy Era: Population-Based Study

The cardiotoxicity during immunotherapy administration leads to mortality by more than 42% and heart disease–related mortality among immunotherapy-linked cancers is still considered to be underestimated. In this study, the advanced stage of non-small cell lung cancer (NSCLC) with heart disease–relat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Safi, Mohammed, Kanesvaran, Ravindran, Alradhi, Mohammed, Al-Danakh, Abdullah, Ping, Feng, Al-Sabai, Najeeb, Shan, Xiu, Liu, Jiwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643546/ https://www.ncbi.nlm.nih.gov/pubmed/33194672 http://dx.doi.org/10.3389/fonc.2020.572380

Ejemplares similares

No Overall Survival Difference in the Immunotherapy Era for Rare Subtypes of Melanoma
por: Safi, Mohammed, et al.
Publicado: (2021)

Commentary: Overall Survival in Heart Disease–Related Death in Non-Small Cell Lung Cancer Patients: Nonimmunotherapy Versus Immunotherapy Era: Population-Based Study
por: Jiao, Yiping, et al.
Publicado: (2021)

Surgery Treatment Improved the Overall Survival Rate in Locoregional Myxoid Leiomyosarcoma than Other Myxosarcomas in the United States
por: Almoiliqy, Marwan, et al.
Publicado: (2021)

Brain and heart‐specific death in cancer patients: Population‐based study
por: Safi, Mohammed, et al.
Publicado: (2021)

Laparoscopic retroperitoneal resection of the duodenal gastrointestinal stromal tumors in neurofibromatosis type 1; Case Report and literature review
por: Abdullah, Al-Danakh, et al.
Publicado: (2022)

A novel nomogram and prognostic factor for metastatic renal cell carcinoma survival in the era of immune checkpoint inhibitors (ICIs)
por: Alradhi, Mohammed, et al.
Publicado: (2023)

Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study
por: Alradhi, Mohammed, et al.
Publicado: (2022)

Immune Checkpoint Inhibitor (ICI) Genes and Aging in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical and Genomic Study
por: Al-Danakh, Abdullah, et al.
Publicado: (2022)

Molecular genetic and clinical characteristic analysis of primary signet ring cell carcinoma of urinary bladder identified by a novel OR2L5 mutation
por: Alradhi, Mohammed, et al.
Publicado: (2022)

PD-1/PDL-1 Inhibitors and Cardiotoxicity; Molecular, Etiological and Management Outlines
por: Safi, Mohammed, et al.
Publicado: (2020)

Interleukin-34 and immune checkpoint inhibitors: Unified weapons against cancer
por: Alshaebi, Fadhl, et al.
Publicado: (2023)

Posterior Tibial Nerve Stimulation for Overactive Bladder: Mechanism, Classification, and Management Outlines
por: Al-Danakh, Abdullah, et al.
Publicado: (2022)

Aberrantly hypermethylated ARID1B is a novel biomarker and potential therapeutic target of colon adenocarcinoma
por: Baldi, Salem, et al.
Publicado: (2022)

ARID1A downregulation promotes cell proliferation and migration of colon cancer via VIM activation and CDH1 suppression
por: Baldi, Salem, et al.
Publicado: (2022)

Quality of life of elderly patients with solid tumours undergoing adjuvant cancer therapy: a systematic review
por: Cheng, Karis Kin-Fong, et al.
Publicado: (2018)

Editorial: Prostate cancer genomics: Application at different stages of a patient’s journey
por: Poon, Darren M. C., et al.
Publicado: (2022)

Age-Based Disparities in Metastatic Melanoma Patients Treated in the Immune Checkpoint Inhibitors (ICI) Versus Non-ICI Era: A Population-Based Study
por: Safi, Mohammed, et al.
Publicado: (2021)

Immune checkpoint inhibitor (ICI) genes and aging in malignant melanoma patients: a clinicogenomic TCGA study
por: Safi, Mohammed, et al.
Publicado: (2022)

Oncological Patients With Endocrine Complications After Immunotherapy With Checkpoint Inhibitors Present Longer Progression-Free and Overall Survival
por: Paschou, Stavroula A., et al.
Publicado: (2022)

The Association of Radiation Dose-Fractionation and Immunotherapy Use With Overall Survival in Metastatic Melanoma Patients
por: Wang, Shang-Jui, et al.
Publicado: (2020)

Protocol for a scoping review of digital health for older adults with cancer and their families
por: Cheng, Karis Kin-Fong, et al.
Publicado: (2020)

Consideration of Surrogate Endpoints for Overall Survival Associated With First-Line Immunotherapy in Extensive-Stage Small Cell Lung Cancer
por: Zhang, Shuang, et al.
Publicado: (2021)

Surveillance Epidemiology and End Results Analysis Demonstrates Improvement in Overall Survival for Cervical Cancer Patients Treated in the Era of Concurrent Chemoradiotherapy
por: Hsu, Howard C., et al.
Publicado: (2015)

Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer Heterogeneity
por: Tsoutsou, Pelagia G., et al.
Publicado: (2018)

A Review of the Abscopal Effect in the Era of Immunotherapy
por: Nabrinsky, Edward, et al.
Publicado: (2022)

Definitive intensity modulated proton re-irradiation for lung cancer in the immunotherapy era
por: Janopaul-Naylor, James R., et al.
Publicado: (2023)

Pseudoprogression of thoracic tumor after radiotherapy in the era of immunotherapy: a case series
por: Xiang, Yongbo, et al.
Publicado: (2023)

Regulation of cell death in cancer—possible implications for immunotherapy
por: Fulda, Simone
Publicado: (2013)

Can bipolar transurethral enucleation of the prostate be a better alternative to the bipolar transurethral resection of the prostate?: A prospective comparative study
por: Abdulwahab Al-radhi, Mohammed, et al.
Publicado: (2021)

Antiangiogenesis for Advanced Non-Small-Cell Lung Cancer in the Era of Immunotherapy and Personalized Medicine
por: Tabchi, Samer, et al.
Publicado: (2017)

Therapy-Induced Tumor Cell Death: Friend or Foe of Immunotherapy?
por: van Schaik, Thijs A., et al.
Publicado: (2021)

The effects of an educational program on depression literacy and stigma among students of secondary schools in Jazan city, 2016: A cluster-randomized controlled trial study protocol
por: Darraj, Hussain, et al.
Publicado: (2018)

Neoadjuvant immunotherapy combined with chemotherapy significantly improved patients’ overall survival when compared with neoadjuvant chemotherapy in non-small cell lung cancer: A cohort study
por: Dai, Fuqiang, et al.
Publicado: (2022)

Early Death and Survival of Patients With Acute Promyelocytic Leukemia in ATRA Plus Arsenic Era: A Population-Based Study
por: Zhu, Hong-Hu, et al.
Publicado: (2021)

Stroke death in patients receiving radiation for head and neck cancer in the modern era
por: Hardy, Sara J., et al.
Publicado: (2023)

Assessment of Overall Survival in Glioma Patients as Predicted by Metabolomic Criteria
por: Gandía-González, María L., et al.
Publicado: (2019)

Allele frequency deviation (AFD) as a new prognostic model to predict overall survival in lung adenocarcinoma (LUAD)
por: Al-Dherasi, Aisha, et al.
Publicado: (2021)

Downregulated ARID1A by miR-185 Is Associated With Poor Prognosis and Adverse Outcomes in Colon Adenocarcinoma
por: Baldi, Salem, et al.
Publicado: (2021)

Association between platelet count and hepatocellular carcinoma overall survival: a large retrospective cohort study
por: Lu, Linbin, et al.
Publicado: (2020)

Abscopal Effect of Radiotherapy in the Immunotherapy Era: Systematic Review of Reported Cases
por: Dagoglu, Nergiz, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lilo07m5iaieos57dsocreenrm